Craig-Hallum Maintains Cellebrite(CLBT.US) With Buy Rating
Deutsche Bank Maintains Cellebrite(CLBT.US) With Buy Rating, Raises Target Price to $18
JPMorgan Adjusts Cellebrite DI Price Target to $17 From $15, Maintains Overweight Rating
Cellebrite DI Is Maintained at Overweight by JP Morgan
Express News | Cellebrite DI Shares Are Trading Higher After Multiple Firms Raised Their Respective Price Targets on the Stock
H&R Block Posts Upbeat Earnings, Joins Alibaba Group, CI&T And Other Big Stocks Moving Higher On Friday
Earnings Call: Cellebrite Reports Robust Q2 Growth With ARR up 26%
Express News | Craig-Hallum Maintains Buy on Cellebrite DI, Raises Price Target to $20
A Quick Look at Today's Ratings for Cellebrite(CLBT.US), With a Forecast Between $17 to $17
Express News | Cellebrite DI Ltd : BofA Global Research Raises Price Objective to $17 From $13
Express News | Cellebrite DI Ltd : Deutsche Bank Raises Target Price to $18 From $15
Analysts Offer Insights on Technology Companies: Coherent Corp (COHR), Cellebrite DI (CLBT) and Grab (GRAB)
Cellebrite DI Price Target Raised to $17.00/Share From $14.00 by Needham
Cellebrite DI Is Maintained at Buy by Needham
Cellebrite DI Analyst Ratings
Express News | Cellebrite DI Ltd : TD Cowen Raises Target Price to $20 From $15
Cellebrite DI Ltd. (CLBT) Q2 2024 Earnings Call Transcript Summary
Cellebrite DI Ltd. (CLBT) Q2 2024 Earnings Call Transcript
Cellebrite DI Reports Mid-Year Financial Shifts
Express News | Cellebrite DI Ltd. : Craig-Hallum Raises Target Price to $20 From $16